Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administered orally in Holstein-Friesian cows

Abstract

Management of neuropathic pain in dairy cattle could be achieved by combination therapy of gabapentin, a GABA analog and meloxicam, an NSAID. This study was designed to determine specifically the depletion of these drugs into milk. Six animals received meloxicam at 1 mg/kg and gabapentin at 10 mg/kg, while another group (n = 6) received meloxicam at 1 mg/kg and gabapentin at 20 mg/kg. Plasma and milk drug concentrations were determined over 7 days postadministration by HPLC/MS followed by noncompartmental pharmacokinetic analyses. The mean (±SD) plasma C[subscript max] and T[subscript max] for meloxicam (2.89 ± 0.48 μg/mL and 11.33 ± 4.12 hours) were not much different from gabapentin at 10 mg/kg (2.87 ± 0.2 μg/mL and 8 hours). The mean (±SD) milk C[subscript max] for meloxicam (0.41 ± 0.16 μg/mL) were comparable to gabapentin at 10 mg/kg (0.63 ± 0.13 μg/mL and 12 ± 6.69 hours). The mean plasma and milk C[subscript max] for gabapentin at 20 mg/kg P.O. were almost double the values at 10 mg/kg. The mean (±SD) milk to plasma ratio for meloxicam (0.14 ± 0.04) was lower than for gabapentin (0.23 ± 0.06). The results of this study suggest that milk from treated cows will have low drug residue concentration soon after plasma drug concentrations have fallen below effective levels.

Description

Keywords

Gabapentin, Meloxicam, Milk, Non-compartmental, Dairy cattle, MRL

Citation